AMRUBICIN THERAPY IMPROVES PATIENTS WITH REFRACTORY SMALL-CELL LUNG CANCER: A SINGLE-ARM CONFIRMATORY CHINESE CLINICAL STUDY

Amrubicin therapy improves patients with refractory small-cell lung cancer: A single-arm confirmatory Chinese clinical study

Our objective was to evaluate an open-label, multicenter, single-arm study JACKET to appraise whether amrubicin therapy improves patients with refractory small-cell lung cancer in Chinese clinical study.Patients (n=95) with refractory small-cell lung cancer received 3 consecutive days amrubicin therapy for 21 days.Overall response rate of response

read more



The atmospheric background situation in northern Scandinavia during January/February 2003 in the context of the MaCWAVE campaign

The atmosphere background wind field controls the propagation of gravity waves from the troposphere through the stratosphere into the mesosphere.During January 2003 the MaCWAVE campaign took place at Esrange, with the purpose of observing Motor Brushes vertically ascending waves induced by orography.Temperature data from the U. Bonn lidar at E

read more